Close
Search
Searching...
No results
    Back
    Corporate news release – Krones expands its capabilities in the growing pharmaceutical market
      09. November 2022

      Corporate news release – Krones expands its capabilities in the growing pharmaceutical market

      00 - Article 31026
      Krones expands its capabilities in the pharmaceutical market with the acquisition of R+D Custom Automation.

      Krones, a leading manufacturer of filling and packaging solutions, has acquired 80.5% of R+D Custom Automation LLC (R+D) with effect from 8 November 2022. Based in Wisconsin, USA, R+D supplies machinery and equipment for the production and filling of containers for the pharmaceutical industry. As a full-service system integrator and specialised equipment manufacturer, R+D has been providing custom engineering solutions to the life science industry for over 40 years. 

      In the 2021 fiscal year, the company generated revenue of some US$43 million with a workforce of more than 60 employees. The purchase price for the stake in R+D is in the mid double-digit millions of US dollars and is met out of available cash funds.

      Krones has an option to buy the remaining 19.5% of the shares in R+D, which remain with the current management. 

      The acquisition of R+D marks a continuation of Krones’ strategy of additional growth outside the beverage industry. It strengthens Krones’ activities in the attractive life science and pharmaceutical market, which shows above-average growth. In R+D, Krones also gains a highly experienced team with innovative solutions and good customer relationships with established pharmaceutical groups.

      Contact
      Olaf Scholz
      Head of Investor Relations
      Böhmerwaldstraße 5
      93073 Neutraubling
      Germany
      T: +49 9401 70-0

      kronesEN
      kronesEN
      0
      10
      1